AEGiS-NYT: H.I.V. Goal Still Possible, U.N. Health Unit Says New York TimesImportant note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow
Print this Article


H.I.V. Goal Still Possible, U.N. Health Unit Says

The New York Times - July 11, 2004
Lawrence K. Altman


The World Health Organization asserted here on Saturday that its goal of delivering antiretroviral therapy to three million people infected with H.I.V. in poor countries by the end of 2005 could still be met despite obstacles that had severely limited the number now under treatment.

The program, known as 3 by 5, has been a subject of debate since the agency's director general, Dr. Lee Jong Wook, announced it last fall. In its first progress report, issued a day before the 15th International AIDS Conference here on Sunday, the World Health Organization estimated that 440,000 people were being treated. That is about twice as many as in 2002, said Dr. Jim Kim, director of the agency's AIDS program. But the agency's goal had been to treat 60,000 more people by now.

Dr. Lee said that the United Nations agency could not let it fail because "the collective response to the H.I.V./AIDS pandemic is the benchmark by which our generation will be judged."

Critics have said the effort was too ambitious. But Dr. Lee said he wanted to set "a difficult, time-limited undertaking that would force us to change the way we work at W.H.O."

Critics also said that affected countries did not have enough workers to deliver the drugs and that the agency did not have enough money. The report was intended "to measure ourselves against specific targets to assess the progress we are making," Dr. Lee wrote. "Progress is not rapid enough," because each day 8,000 people are dying from AIDS, the report said, while asserting that the slow start still would generate enough pressure to speed the effort later.

The agency attributed slow progress to a lack of money, but that has improved through contributions from Canada, Britain and Sweden.

At a news conference here on Saturday, agency officials were long on promises but less specific about the effort that the agency, which is based in Geneva, is conducting with government and private groups.

The agency published the estimated number of people receiving antiretroviral treatment by country for 49 countries. The total was 327,000. The agency did not provide the list of countries with the remaining 113,000 people being treated.

Stephen Lewis, the special United Nations envoy for AIDS in Africa, said he felt certain from visits to a number of countries that the 3 by 5 plan would succeed in Africa.

Since December, 56 countries have asked the agency for help in developing national antiretroviral programs, more than expected. The agency said it had sent workers to more than 20 of the countries.Twelve countries have established official treatment goals that meet the 3 by 5 objective of providing treatment for 50 percent of those in need.

Only Botswana, Indonesia and Uganda have published such plans. Botswana is treating 18,000 people, with a goal of 30,000; Indonesia is treating 1,500, with a goal of 3,500; and Uganda is treating 20,000, with a goal of 55,000, said Melanie Zipperer, an agency spokeswoman.

The agency said progress has been slowed by the time it takes to develop clear, standard and simplified technical guidelines and training materials, and by the time needed to develop standards and processes to certify workers. Dr. Peter Piot, the director of the United Nations AIDS program, a partner in the 3 by 5 effort, said, "We have to be frank and admit that we have a long way to go."
040711
NYT040707


Copyright © 2004 - The New York Times Company. All Rights Reserved. All New York Times articles contained on the AEGiS web site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of The New York Times Company. You may not alter or remove any trademark, copyright or other notice from copies of the content. However, you may download articles (one machine readable copy and one print copy per page) for your personal, noncommercial use only.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .